Trial intelligence / Profile preview

Exparel for Postoperative Pain Relief in Mandibular Third Molar Extractions

NCT05374499Phase 4Completed

Sponsor
University of Southern California
Start
Sep 2022
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by University of Southern California. Started Sep 2022; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05374499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05374499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call